AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms
It will be conducted as a Quasi Experimental study across pediatric therapy centers, specialized autism clinics, and special schools. Using non-probability convenience sampling, the study will enroll Autistic children aged 6-10 years who exhibit sensory processing difficulties, motor skill delays, and sleep disturbances. Exclusion criteria include other neurological or developmental disorders and children with major physical problems. Motor skills will be assessed with the Bruininks-Oseretsky Test of Motor Proficiency (BOT-2), and sleep quality will be measured using the Children's Sleep Habits Questionnaire (CSHQ). Participants will be receiving Wilbarger DPPT along with their usual therapy sessions, which may include general occupational therapy, physical therapy, ABA etc. The DPPT intervention will occur three times per week for six weeks, with each session lasting approximately 30-4
Sign in to get the eligibility rules as simple questions to take to your doctor.
AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy
HealthTeky